(Q36929605)

English

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial (English)

1 reference

Europe PubMed Central

17 August 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Alan R. Kristal

object named as

Alan R Kristal

9

0 references

David F. Penson

object named as

David F Penson

7

0 references

Marian L Neuhouser

1

object named as

Marian L Neuhouser

1 reference

Europe PubMed Central

17 August 2017

Jeannette M. Schenk

2

object named as

Jeannette Schenk

1 reference

Europe PubMed Central

17 August 2017

author name string

Yoon Ju Song

3

1 reference

Europe PubMed Central

17 August 2017

Catherine M Tangen

4

1 reference

Europe PubMed Central

17 August 2017

Phyllis J Goodman

5

1 reference

Europe PubMed Central

17 August 2017

Michael Pollak

6

1 reference

Europe PubMed Central

17 August 2017

Ian M Thompson

8

1 reference

Europe PubMed Central

17 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

68

1 reference

Europe PubMed Central

17 August 2017

13

1 reference

Europe PubMed Central

17 August 2017

1477-1486

1 reference

Europe PubMed Central

17 August 2017

Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Insulin-like growth factors and neoplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Pathology of benign prostatic hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Prostatic hyperplasia: an unknown feature of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

The IGF axis in the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Nutritional regulation of the insulin-like growth factors

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

29 September 2017

Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

27 June 2018

Hormonal profile of diabetic men and the potential link to prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20819

21 January 2018

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphoc

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Insulin-like growth factors and risk of benign prostatic hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Natural history and epidemiology of benign prostatic hyperplasia: relationship among urologic measures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564287

4 September 2018

Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factors and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third national health and nutrition examination survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifestyle factors and insulin-like growth factor 1 levels among elderly men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18618736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PROS.20819

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36929605&oldid=1663601846"